Urea c 13
Urea c 13 is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| 45% urea cream 2% salicylic acid | C200263 | 2024-10-17 |
| 48% urea cream | C200263 | 2024-10-15 |
| aoao repair feet cream | C200263 | 2024-08-31 |
| aoao repair foot cream | C200263 | 2024-09-03 |
| barubt urea cream | C200263 | 2024-09-18 |
| barubt urea moisturizing cream | C200263 | 2024-10-27 |
| cem-urea | unapproved drug other | 2011-08-16 |
| ciclopirox 3% / itraconazole 5% / urea 20% | unapproved drug other | 2019-05-20 |
| drymatine 20% urea cream | C200263 | 2024-11-05 |
| foot cream 42% urea | C200263 | 2024-10-17 |
Show 12 more
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
112 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Infections | D007239 | EFO_0000544 | — | 1 | — | 4 | 2 | 14 | 21 |
| Helicobacter infections | D016481 | EFO_1000961 | — | — | 1 | — | 1 | 9 | 11 |
| Communicable diseases | D003141 | — | — | — | — | — | 1 | 9 | 10 |
| Kidney diseases | D007674 | EFO_0003086 | N08 | — | — | — | 1 | 3 | 4 |
| Chronic renal insufficiency | D051436 | — | N18 | — | — | — | 1 | 2 | 3 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | — | 1 | 1 | 2 |
| Atrial fibrillation | D001281 | EFO_0000275 | I48.0 | — | — | — | 1 | — | 1 |
| Hiv infections | D015658 | EFO_0000764 | B20 | — | — | — | 1 | — | 1 |
| Hiv | D006678 | — | — | — | — | — | 1 | — | 1 |
| Acquired immunodeficiency syndrome | D000163 | EFO_0000765 | B20 | — | — | — | 1 | — | 1 |
Show 4 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Gastritis | D005756 | EFO_0000217 | K29.7 | — | — | 1 | — | 5 | 6 |
| Wounds and injuries | D014947 | — | T14.8 | — | 1 | 1 | — | 2 | 3 |
| Hyperammonemia | D022124 | HP_0001987 | E72.20 | — | 2 | 1 | — | — | 2 |
| Non-alcoholic fatty liver disease | D065626 | EFO_0003095 | K75.81 | — | 1 | 1 | — | 1 | 2 |
| Fatty liver | D005234 | EFO_0003934 | — | — | 1 | 1 | — | 1 | 2 |
| Radiodermatitis | D011855 | — | L58 | — | 1 | 1 | — | — | 2 |
| Crohn disease | D003424 | EFO_0000384 | K50 | — | — | 1 | — | — | 1 |
| Inborn errors metabolism | D008661 | — | — | — | 1 | 1 | — | — | 1 |
| Head and neck neoplasms | D006258 | — | — | — | — | 1 | — | — | 1 |
| Healthy volunteers/patients | — | — | — | — | — | 1 | — | — | 1 |
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Covid-19 | D000086382 | — | — | 1 | 2 | — | — | 4 | 7 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 1 | 2 | — | — | — | 3 |
| Inborn urea cycle disorders | D056806 | — | E72.2 | — | 1 | — | — | 2 | 3 |
| Leukemia | D007938 | — | C95 | 1 | 1 | — | — | 1 | 3 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 1 | 1 | — | — | 1 | 3 |
| Myeloid leukemia | D007951 | — | C92 | 1 | 1 | — | — | 1 | 3 |
| Lymphoma | D008223 | — | C85.9 | 1 | 1 | — | — | — | 2 |
| Virus diseases | D014777 | — | B34 | 1 | 1 | — | — | — | 2 |
| Neoplasms | D009369 | — | C80 | 1 | 1 | — | — | — | 2 |
| Coronavirus infections | D018352 | EFO_0007224 | B34.2 | — | 1 | — | — | 1 | 2 |
Show 16 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Dyspepsia | D004415 | EFO_0008533 | K30 | 1 | — | — | — | 3 | 4 |
| Syndrome | D013577 | — | — | 1 | — | — | — | 1 | 2 |
| Colorectal neoplasms | D015179 | — | — | 1 | — | — | — | 1 | 2 |
| Porokeratosis | D017499 | — | L56.5 | 2 | — | — | — | — | 2 |
| Malformed nails | D009264 | — | Q84.5 | 2 | — | — | — | — | 2 |
| Pachyonychia congenita | D053549 | — | — | 2 | — | — | — | — | 2 |
| Palmoplantar keratoderma | D007645 | HP_0000982 | — | 2 | — | — | — | — | 2 |
| Type 1 diabetes mellitus | D003922 | EFO_0001359 | E10 | 1 | — | — | — | — | 1 |
| Ebola hemorrhagic fever | D019142 | EFO_0007243 | A98.4 | 1 | — | — | — | — | 1 |
| Marburg virus disease | D008379 | EFO_0007358 | A98.3 | 1 | — | — | — | — | 1 |
Show 7 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Cardiovascular diseases | D002318 | HP_0001626 | — | — | — | — | — | 4 | 4 |
| Acute kidney injury | D058186 | HP_0001919 | N17 | — | — | — | — | 4 | 4 |
| Stomach neoplasms | D013274 | EFO_0003897 | C16 | — | — | — | — | 3 | 3 |
| Liver diseases | D008107 | HP_0002910 | K70-K77 | — | — | — | — | 2 | 2 |
| Inborn genetic diseases | D030342 | EFO_0000508 | — | — | — | — | — | 2 | 2 |
| Chronic kidney failure | D007676 | EFO_0003884 | N18.9 | — | — | — | — | 2 | 2 |
| Renal insufficiency | D051437 | HP_0000083 | N19 | — | — | — | — | 2 | 2 |
| Sepsis | D018805 | HP_0100806 | A41.9 | — | — | — | — | 2 | 2 |
| Toxemia | D014115 | — | — | — | — | — | — | 2 | 2 |
| Malnutrition | D044342 | EFO_0008572 | E40-E46 | — | — | — | — | 2 | 2 |
Show 102 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | Urea c 13 |
| INN | — |
| Description | ((13)C)urea is a (13)C-modified compound that is urea in which the carbon is present as its (13)C isotope. It is a (13)C-modified compound and a one-carbon compound. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | N[13C](N)=O |
Identifiers
| PDB | — |
| CAS-ID | 58069-82-2 |
| RxCUI | — |
| ChEMBL ID | CHEMBL2096648 |
| ChEBI ID | 32285 |
| PubChem CID | — |
| DrugBank | — |
| UNII ID | — |
Target
No data
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 3,735 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
42 adverse events reported
View more details
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use